F. Castinetti, A. Barlier, F. Sebag, D. Taieb
Oncologie, Vol.21, No.2, pp. 105-111, 2019, DOI:10.3166/onco-2019-0050
Abstract Pheochromocytoma and paraganglioma are
tumors leading to increased morbidity and mortality. Over
the last 20 years, several major advances allowed a better
characterization of these tumors, either from an imaging or
from a genetic viewpoint. This is especially the case for the
hereditary characteristics of these tumors, as roughly 20 new
genes have been identified. This is why the initial steps of
the management of a pheochromocytoma and/or a paraganglioma now require a dedicated tertiary referral center.
The aim of this review is to depict the diagnostic steps of
these tumors, so as to allow the clinician to determine the… More >